Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
  • Affiliated Brands
    Academy of Oncology Nurse & Patient Navigators
    The Academy of Oncology Nurse & Patient Navigators (AONN+) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. Our organization of over 8,900 members was founded in May 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services to better manage the complexities of the cancer care treatment continuum for their patients. We view our organization as one consisting of “professional patient advocates” and, to that end, we support and serve our members.
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
  • Healthcare Providers
  • Contribute

Drugs for Bladder Cancer (Urothelial Carcinoma)

Adstiladrin (nadofaragene firadenovec-vncg)

Drug company: Ferring Pharmaceuticals
844-623-6669

Ferring Pharmaceuticals offers 2 financial assistance programs for patients using Adstiladrin:

ADSTILADRIN Copay Program

Ferring Access Support Patient Assistance Program

Balversa (erdafitinib)

Drug company: Janssen
866-378-1910

Janssen offers 2 financial assistance programs for patients who have been prescribed Balversa:

Janssen CarePath Savings Program

Johnson & Johnson Patient Assistance Foundation

Bavencio (avelumab)

Drug company: EMD Serono
844-826-8371

EMD Serono offers 2 financial assistance programs for patients using Bavencio:

CoverOne Co-Pay Assistance Program

CoverOne Patient Assistance Program

Jelmyto (mitomycin)

Drug company: UroGen Pharma
855-535-6986

UroGen Support offers 2 financial assistance programs for patients who have been prescribed Jelmyto:

UroGen Support Copay Program

UroGen Support Patient Assistance Program

Keytruda (pembrolizumab)

Drug company: Merck
855-257-3932

Merck offers 2 financial assistance programs for patients using Keytruda:

Merck Co-pay Assistance Program

Merck Patient Assistance Program

Opdivo (nivolumab)

Drug company: Bristol Myers Squibb
800-861-0048

Bristol Myers Squibb Access Support offers 2 financial assistance programs for patients using Opdivo:

BMS Oncology Co-Pay Assistance Program

Bristol Myers Squibb Patient Assistance Foundation

Padcev (enfortumab vedotin-ejfv) Injection

Drug company: Astellas/Seagen
888-402-0627

Astellas and Seagen offer 2 financial assistance programs for patients using Padcev:

Padcev Copay Assistance Program

Padcev Patient Assistance Program

Trodelvy (sacituzumab govitecanhziy) Injection

Drug company: Gilead
844-876-3358

Gilead, through Trodelvy Access Support, offers 2 financial assistance programs for patients using Trodelvy:

Trodelvy Savings Program

Gilead Patient Assistance Program